HopeStage
Back to all studies
CompletedNCT04852302

CALM therapy for people with a primary brain tumor

About this titleRead the official source — NCT04852302
Behavioural studyAges 18+United StatesDepression
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 18 years.

What did participation involve?

The protocol includes: Completing questionnaires.

Listed locations
BethesdaSee all locations and recruitment
Participation duration
About 6 months

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: August 11, 2021
Recruitment status
Completed
Enrollment listed in the registry
19
Sponsor
National Cancer Institute (NCI)
Sponsor type
Research institute
Study type
Behavioral
Intervention type
Behavioural
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT04852302
Official title
Show the full official title

Managing Cancer and Living Meaningfully (CALM) Therapy in Individuals Diagnosed With a Primary Central Nervous System Tumor

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Bethesda

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What did participation involve?

The protocol called for participants to complete questionnaires.

Who is behind this study?

The study sponsor is National Cancer Institute (NCI), a research institute.

Who was this study for?

Listed age limits: from 18 years.

How long was participation planned to last?

Participation was planned to last about 6 months.

Want to explore more studies?

Explore studies